NCT02389075View on ClinicalTrials.gov

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

Active, not recruitingOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Inflammatory Bowel Diseases (IBD)Ankylosing Spondylitis (AS)
Interventions
PROCEDURE

Pinch biopsies

Biopsies obtained during colonoscopy or flexible sigmoidoscopy.

PROCEDURE

Flexible sigmoidoscopy

Offered to subjects with ankylosing spondylitis who do not meet criteria for colonoscopy

Trial Locations (1)

80045

University of Colorado, Denver

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of Colorado, Denver

OTHER

NCT02389075 - The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter